Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects.
Tiberti C, Nenna R, Tromba V, Filardi T, Petrarca L, Silvestri F, Fassino V, Montuori M, Mancino E, Lenzi A, Midulla F, Costantino F, Morano S. Tiberti C, et al. Among authors: filardi t. Acta Diabetol. 2023 Oct;60(10):1309. doi: 10.1007/s00592-023-02152-6. Acta Diabetol. 2023. PMID: 37474814 Free PMC article. No abstract available.
IgA anti-transglutaminase autoantibodies at type 1 diabetes onset are less frequent in adult patients and are associated with a general celiac-specific lower immune response in comparison with nondiabetic celiac patients at diagnosis.
Tiberti C, Panimolle F, Bonamico M, Shashaj B, Filardi T, Lucantoni F, Nenna R, Costantino F, Lenzi A, Morano S. Tiberti C, et al. Among authors: filardi t. Diabetes Care. 2012 Oct;35(10):2083-5. doi: 10.2337/dc11-2171. Epub 2012 Jul 18. Diabetes Care. 2012. PMID: 22815294 Free PMC article.
Long-standing type 1 diabetes: patients with adult-onset develop celiac-specific immunoreactivity more frequently than patients with childhood-onset diabetes, in a disease duration-dependent manner.
Tiberti C, Panimolle F, Bonamico M, Filardi T, Pallotta L, Nenna R, Pontone S, Dotta F, Pugliese G, Lenzi A, Balducci S, Morano S. Tiberti C, et al. Among authors: filardi t. Acta Diabetol. 2014 Aug;51(4):675-8. doi: 10.1007/s00592-013-0536-0. Epub 2014 Jan 23. Acta Diabetol. 2014. PMID: 24452477
Endothelial dysfunction markers as a therapeutic target for Sildenafil treatment and effects on metabolic control in type 2 diabetes.
Mandosi E, Giannetta E, Filardi T, Lococo M, Bertolini C, Fallarino M, Gianfrilli D, Venneri MA, Lenti L, Lenzi A, Morano S. Mandosi E, et al. Among authors: filardi t. Expert Opin Ther Targets. 2015;19(12):1617-22. doi: 10.1517/14728222.2015.1066337. Epub 2015 Jul 15. Expert Opin Ther Targets. 2015. PMID: 26178526 Clinical Trial.
Consumption of extra-virgin olive oil rich in phenolic compounds improves metabolic control in patients with type 2 diabetes mellitus: a possible involvement of reduced levels of circulating visfatin.
Santangelo C, Filesi C, Varì R, Scazzocchio B, Filardi T, Fogliano V, D'Archivio M, Giovannini C, Lenzi A, Morano S, Masella R. Santangelo C, et al. Among authors: filardi t. J Endocrinol Invest. 2016 Nov;39(11):1295-1301. doi: 10.1007/s40618-016-0506-9. Epub 2016 Jun 25. J Endocrinol Invest. 2016. PMID: 27344308
72 results